HUTCHMED (China) Ltd (HCM)
16.75
-0.10
(-0.59%)
USD |
NASDAQ |
Nov 15, 16:00
16.75
0.00 (0.00%)
After-Hours: 18:43
HUTCHMED Shareholders Equity (Quarterly): 740.08M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 740.08M |
| June 30, 2024 | 740.08M |
| December 31, 2023 | 730.54M |
| June 30, 2023 | 782.04M |
| June 30, 2023 | 782.04M |
| December 31, 2022 | 610.37M |
| June 30, 2022 | 799.73M |
| June 30, 2022 | 799.73M |
| June 30, 2021 | 984.80M |
| June 30, 2021 | 984.80M |
| March 31, 2021 | 428.27M |
| June 30, 2020 | 342.12M |
| June 30, 2020 | 342.12M |
| June 30, 2019 | 347.89M |
| June 30, 2019 | 347.89M |
| March 31, 2019 | 375.77M |
| June 30, 2018 | 431.73M |
| June 30, 2018 | 431.73M |
| December 31, 2017 | 461.73M |
| June 30, 2017 | 189.38M |
| June 30, 2017 | 189.38M |
| Date | Value |
|---|---|
| December 31, 2016 | 184.27M |
| June 30, 2016 | 178.45M |
| June 30, 2016 | 178.45M |
| December 31, 2015 | 83.36M |
| September 30, 2015 | 82.16M |
| June 30, 2015 | 98.62M |
| June 30, 2015 | 98.62M |
| December 31, 2014 | 39.15M |
| June 30, 2014 | 94.09M |
| June 30, 2014 | 94.09M |
| December 31, 2013 | 88.87M |
| June 30, 2013 | 84.80M |
| June 30, 2013 | 84.80M |
| December 31, 2012 | 70.58M |
| June 30, 2012 | 64.32M |
| June 30, 2012 | 64.32M |
| December 31, 2011 | 64.78M |
| December 31, 2010 | 59.55M |
| June 30, 2010 | 64.77M |
| June 30, 2010 | 64.77M |
| December 31, 2009 | 65.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
342.12M
Minimum
Jun 2020
984.80M
Maximum
Jun 2021
697.44M
Average
740.08M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 48.46B |
| AstraZeneca PLC | 39.51B |
| Sino Biopharmaceutical Ltd | 4.519B |
| Regencell Bioscience Holdings Ltd | 8.219M |
| Prenetics Global Ltd | 188.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.261B |
| Total Liabilities (Quarterly) | 508.85M |
| Debt to Equity Ratio | 0.1109 |
| Current Ratio | 2.612 |
| Net Debt Paydown Yield | -0.73% |